Refereed journal article or data article (A1)
Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
List of Authors: Mattila M., Erlund I., Lee H.-S., Niinistö S., Uusitalo U., Andrén Aronsson C., Hummel S., Parikh H., Rich S.S., Hagopian W., Toppari J., Lernmark Å., Ziegler A.G., Rewers M., Krischer J.P., Norris J.M., Virtanen S.M.; for the TEDDY Study Group
Publisher: Springer
Publication year: 2020
Journal: Diabetologia
Journal name in source: Diabetologia
Volume number: 63
Issue number: 2
Start page: 278
End page: 286
Number of pages: 9
ISSN: 0012-186X
DOI: http://dx.doi.org/10.1007/s00125-019-05028-z
URL: https://link.springer.com/article/10.1007/s00125-019-05028-z
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/44452436
Aims/hypothesis: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes.
Methods: We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification.
Results: Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]).
Conclusions/interpretation: Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings.
Data availability: The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy.
Downloadable publication This is an electronic reprint of the original article. |  |
